Schiavone, M. L.
Crisafulli, L.
Camisaschi, C.
De Simone, G.
Liberati, F. R.
Palagano, E.
Rucci, N.
Ficara, F.
Sobacchi, Cristina http://orcid.org/0000-0002-2684-7184
Funding for this research was provided by:
Ministero della Salute (RF-2018-12367680)
Fondazione Beppe e Nuccy Angiolini Onlus (Fondazione Beppe e Nuccy Angiolini Onlus)
Article History
Received: 12 February 2024
Accepted: 16 June 2024
First Online: 6 July 2024
Declarations
:
: Ethics approval for all animal procedures was obtained from the Institutional Animal Care and Use Committee of Humanitas Research Hospital and from the Ministry of Health ([approval title: “Dissecting the neglected link between RANKL cytokine and stemness features with high relevance in osteoporosis”], [approval no. 543/2019-PR], and [Date: July 25, 2019]). Animal care and experimental procedures were performed in accordance with established standard protocols. The whole study was approved by the Comitato Etico Indipendente of Humanitas Research Hospital IRCCS ([approval title: “Studio del ruolo della citochina RANKL in riferimento a caratteristiche di staminalità altamente rilevanti in un quadro di osteoporosi”], [approval no. 334/2019, Date: May 14, 2019] and [no. 2577, Date June 8, 2020 – for the initiation of the study]). The human cells used in the study were purchased from Stem Cell Technologies. All animal studies were reported in compliance with the ARRIVE guidelines ( ).
: Not applicable.
: The authors declare that they have no conflict of interest.